HOME >> BIOLOGY >> NEWS
Gene therapy for muscular dystrophy

In a study of Muscular Dystrophy, scientists at the University of Pennsylvania School of Medicine have found that a common delivery system used in treating the disease through gene therapy may trigger an immune response in mice unless it is used in combination with a muscle-specific promoter that localizes the expression of genetic material.

The study findings are published in the new issue of the journal Human Gene Therapy.

Even when you use low-levels of a promoter that is not restricted to the afflicted area, you run the risk that you will immunize the patient against the very protein you are trying to get made, said H. Lee Sweeney, PhD, chairman of the Department of Physiology at Penn and lead author of the study. This is relevant because some of the clinical trials that have been started are not using restricted promoters. The journal wanted to get this message out there.

In their published findings, the Penn researchers state that it is crucial to establish which method should be used before expanding clinical trials.

The scientists used two groups of mice that had been engineered to lack a protein called gamma sarcloc-glycan (gsg) in their muscles, which is the same protein that is missing in muscluar dystrophy (MD).

The researchers administered the protein to both groups of mice by enclosing the gsg in the recombinant adeno-associated virus (rAAV) a commonly used vector that has been described in previous scientific research as non-immunogenic.

In one group of mice, the rAAV included a cytomegalovirus (CMV) promoter -- which will express the DNA material it carries in any tissue. The results Sweeney found: Although we didnt see the immune response in the CMV promoter in a large percentage of the mice we did see it.

In the second group of mice, when the rAAV that contained the gsg material was delivered under the control of the muscle creatine kinase promoter which is muscle-specific -- there was no immune response.

What
'"/>

Contact: Ellen O'Brien
ellen.obrien@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
21-Jan-2001


Page: 1 2

Related biology news :

1. Targeted therapy knocks out pediatric brain cancer in mice
2. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
3. Columbia research to examine gene influence on severity of peridontal disease, therapy response
4. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
5. The search for a kinder, gentler chemotherapy
6. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
7. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
8. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
9. Jefferson Lab detector technology aids development of cystic fibrosis therapy
10. Stroking up cellular therapy
11. Smart gene therapy protects against damage from heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
(Date:3/22/2017)... , March 21, 2017   Neurotechnology ... object recognition technologies, today announced the release of ... (SDK), which provides improved facial recognition using up ... on a single computer. The new version uses ... improve accuracy, and it utilizes a Graphing Processing ...
(Date:3/22/2017)... Vigilant Solutions , a vehicle location ... announced today the appointment of retired FBI special agent ... business development. Mr. Sheridan brings more than ... focus on the aviation transportation sector, to his new ... Sheridan served as the Aviation Liaison Agent Coordinator (ALAC) ...
Breaking Biology News(10 mins):
(Date:5/18/2017)... ... May 17, 2017 , ... ... stress expertise, and further enhances its scientific power by providing investigators access ... Ph.D., has agreed to join the scientific advisory board. “We are committed ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... business process optimization firm for the life sciences and healthcare industries, is honored ... and Traceability for Medical Devices conference in Brussels, Belgium. , Crowley played a ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... today that their Chief Executive Officer, Maik Jornitz, was recognized as a Top ... Power List celebrates 100 individuals “involved in bettering the pharma industry and bringing ...
(Date:5/18/2017)... ... ... was notified earlier this year that his company Asymmetrex had been selected as ... Review , he was not surprised as others might be. Sherley says, “I felt ... Valley was particularly meaningful. Our selection by The Silicon Review may seem ...
Breaking Biology Technology:
Cached News: